Association between Pretreatment Levels of Serum Vascular Endothelial Growth Factor (VEGF) and Survival Outcomes in Locally Advanced Cervical Cancer Patients

Kanyarat Katanyoo; Kanisa Rongsriyam; Marisa Chongtanakon

doi:10.4236/jct.2013.410178

Association between Pretreatment Levels of Serum Vascular Endothelial Growth Factor (VEGF) and Survival Outcomes in Locally Advanced Cervical Cancer Patients

Journal of Cancer Therapy ◽

10.4236/jct.2013.410178 ◽

2013 ◽

Vol 04 (10) ◽

pp. 1478-1484

Author(s):

Kanyarat Katanyoo ◽

Kanisa Rongsriyam ◽

Marisa Chongtanakon

Keyword(s):

Cervical Cancer ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Cancer Patients ◽

Locally Advanced ◽

Survival Outcomes ◽

Vascular Endothelial ◽

Advanced Cervical Cancer ◽

Locally Advanced Cervical Cancer ◽

Endothelial Growth Factor

Download Full-text

Carboplatin-based neoadjuvant treatment with peripheral blood stem cell and growth factor support in locally advanced cervical cancer patients with bulky metastatic lymph nodes

European Journal of Obstetrics & Gynecology and Reproductive Biology ◽

10.1016/j.ejogrb.2006.04.005 ◽

2007 ◽

Vol 131 (2) ◽

pp. 236-238 ◽

Cited By ~ 2

Author(s):

Gabriella Ferrandina ◽

Alessandro Perillo ◽

Luca Pierelli ◽

Mariagrazia Distefano ◽

Giuseppe D’Agostino ◽

...

Keyword(s):

Cervical Cancer ◽

Stem Cell ◽

Growth Factor ◽

Cancer Patients ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Advanced Cervical Cancer ◽

Locally Advanced Cervical Cancer

Download Full-text

Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.05.003 ◽

2005 ◽

Vol 98 (3) ◽

pp. 467-483 ◽

Cited By ~ 35

Author(s):

Subbi P. Mathur ◽

Rajesh S. Mathur ◽

Elizabeth A. Gray ◽

Derrick Lane ◽

Paul G. Underwood ◽

...

Keyword(s):

Cervical Cancer ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Vascular Endothelial ◽

Advanced Cervical Cancer ◽

Factor Ii ◽

Igf Binding ◽

Factor C ◽

Igf Binding Protein ◽

Endothelial Growth Factor

Download Full-text

Corrigendum to “Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B” [Gynecol. Oncol. 98 (2005) 467–483]

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.12.018 ◽

2006 ◽

Vol 101 (1) ◽

pp. 186

Author(s):

Subbi P. Mathur ◽

Rajesh S. Mathur ◽

Elizabeth A. Gray ◽

Derrick Lane ◽

Paul G. Underwood ◽

...

Keyword(s):

Cervical Cancer ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Vascular Endothelial ◽

Advanced Cervical Cancer ◽

Factor Ii ◽

Igf Binding ◽

Factor C ◽

Igf Binding Protein ◽

Endothelial Growth Factor

Download Full-text

Valor prognóstico da expressão tumoral e estromal das metaloproteases de matriz 2, 9, 14, dos inibidores teciduais de metaloproteases 1 e 2 e do fator de crescimento endotelial de crescimento endotelial vascular A em pacientes com câncer do colo do útero Prognostic value of tumoral and stromal expression of matrix metalloproteinases 2, 9, 14, tissue inhibitors of matrix metalloproteinase 1, 2 and vascular endothelial growth factor A for cervical cancer patients

10.47749/t/unicamp.2019.1091885 ◽

2019 ◽

Author(s):

Jordana Maria Azevedo Martins

Keyword(s):

Cervical Cancer ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Matrix Metalloproteinases ◽

Matrix Metalloproteinase ◽

Cancer Patients ◽

Prognostic Value ◽

Vascular Endothelial ◽

Matrix Metalloproteinase 1 ◽

Endothelial Growth Factor

Download Full-text

Dynamics of circulating vascular endothelial growth factor‐A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13965 ◽

2019 ◽

Vol 85 (8) ◽

pp. 1781-1789

Author(s):

Cong Zhou ◽

Sarah Taylor ◽

Jonathan Tugwood ◽

Kathryn Simpson ◽

Gordon C. Jayson ◽

...

Keyword(s):

Cervical Cancer ◽

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Cancer Patients ◽

Vascular Endothelial ◽

Recurrent Cervical Cancer ◽

Endothelial Growth Factor

Download Full-text

361: Serum Levels of Angiogenin and Vascular Endothelial Growth Factor (VEGF) Predict Metastatic Disease in Renal Cell Cancer Patients

The Journal of Urology ◽

10.1016/s0022-5347(18)34614-7 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 99-99 ◽

Cited By ~ 1

Author(s):

Marcus Horstmann ◽

Axel S. Merseburger ◽

Markus A. Kuczyk ◽

Arnulf Stenzl ◽

Karl-Horst Bichler ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Cancer Patients ◽

Renal Cell Cancer ◽

Metastatic Disease ◽

Renal Cell ◽

Cell Cancer ◽

Serum Levels ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Chemotherapy-Related Leukopoenia as a Biomarkers Predicting Survival Outcomes in Locally Advanced Cervical Cancer

10.26226/morressier.5770e29dd462b80290b4c25f ◽

2016 ◽

Author(s):

Giorgio Bogani

Keyword(s):

Cervical Cancer ◽

Locally Advanced ◽

Survival Outcomes ◽

Advanced Cervical Cancer ◽

Locally Advanced Cervical Cancer

Download Full-text

IMPACT OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND HYPOXIA – INDUCTIBLE FACTOR-1ALPHA (HIF-1) EXPRESSION ON RESPONSE TO RADIO-CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CARCINOMA.

10.26226/morressier.597eedbdd462b80296ca0abb ◽

2017 ◽

Author(s):

Madani Julia

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Cervical Carcinoma ◽

Locally Advanced ◽

Vascular Endothelial ◽

Advanced Cervical Carcinoma ◽

Endothelial Growth Factor ◽

Radio Chemotherapy

Download Full-text

Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2013.06.003 ◽

2013 ◽

Vol 39 (9) ◽

pp. 1025-1029 ◽

Cited By ~ 4

Author(s):

F. Fanfani ◽

A. Fagotti ◽

M.L. Gagliardi ◽

G. Ferrandina ◽

G. Monterossi ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Patients ◽

Locally Advanced ◽

Advanced Cervical Cancer ◽

Adjuvant Chemoradiation ◽

Locally Advanced Cervical Cancer ◽

Cone Biopsy

Download Full-text

Oncothermia in HIV-Positive and -Negative Locally Advanced Cervical Cancer Patients in South Africa

Conference Papers in Medicine ◽

10.1155/2013/293968 ◽

2013 ◽

Vol 2013 ◽

pp. 1-3

Author(s):

Carrie A. Strauss ◽

Jeffrey A. Kotzen ◽

Ans Baeyens ◽

Irma Maré

Keyword(s):

South Africa ◽

Cervical Cancer ◽

Cancer Patients ◽

Standard Treatment ◽

Locally Advanced ◽

External Beam Radiation ◽

Hiv Positive ◽

Advanced Cervical Cancer ◽

Treatment Toxicity ◽

Locally Advanced Cervical Cancer

Aim. Investigate the clinical, economic, and cellular effects of the addition of oncothermia to standard treatment for HIV-positive and -negative locally advanced cervical cancer patients in public healthcare in South Africa. Objectives. Evaluate the effect that the addition of oncothermia has on local disease control, progression-free survival, overall survival at 2 years, treatment toxicity, quality of life, economic impact, and HIV status of participants. Radiobiology investigations will evaluate thermoradiosensitivity and the molecular markers for thermoradiosensitivity. Methodology. Phase III randomised clinical trial involving 236 HIV-negative and -positive stage IIb-III locally advanced cervical cancer patients. Treatment includes cisplatin, external beam radiation, and brachytherapy. The study group will receive oncothermia treatments. Participants will be monitored for two years after completion of treatment. Hypothesis. The addition of oncothermia to standard treatment protocols will result in improved clinical response without increasing treatment toxicity in HIV-positive patients or raising healthcare costs.

Download Full-text